Drug-drug Interaction of Empagliflozin (BI 10773) and Simvastatin

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The objective of the study is to investigate the drug-drug interaction potential between BI 10773 and simvastatin.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Empagliflozin; Simvastatin

Criteria

Inclusion criteria:

• healthy male and female subjects

Exclusion criteria:

• Any relevant deviation from healthy conditions